The bipartisan 21st Century Cures Act, headed to theSenate after passage in the House by a huge margin—392 to 26—ismeeting with mixed reactions by many.

Some of its best features are money to fight the opioidepidemic, funding for National Institutes of Health projects—thecancer “moonshot,” the BRAIN Initiative and the Precision MedicineInitiative—and support for mental health.

Benefits to the pharmaceutical industry

But Business Insider reported that on the flip side arefeatures that spurred former supporters of the bill SenatorsElizabeth Warren, D-Massachusetts, and Bernie Sanders, I-Vermont,to withdraw their backing, with both declaring it a giveaway to thepharmaceutical industry.

Continue Reading for Free

Register and gain access to:

  • Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
  • Educational webcasts, white papers, and ebooks from industry thought leaders
  • Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

Consumer Driven Health Care
Cost-Containment
Employer-Paid